Natus Medical Incorporated (NTUS) |
| 32.96 0 (0%) 04-24 15:47 |
| Open: | 32.9 |
| High: | 33.07 |
| Low: | 32.84 |
| Volume: | 132,698 |
| Market Cap: | 0(M) |
| PE Ratio: | 86.74 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 6.35 |
| Resistance 1: | 5.44 |
| Pivot price: | 5.21 |
| Support 1: | 5.13 |
| Support 2: | 4.94 |
| 52w High: | 33.93 |
| 52w Low: | 20.902 |
Natus Medical Incorporated is a global provider of advanced medical device solutions, dedicated to the diagnosis and treatment of conditions affecting the central nervous and sensory systems. The company's offerings are utilized for the screening, detection, therapeutic intervention, ongoing monitoring, and tracking of a wide array of prevalent medical issues. Its product portfolio addresses critical areas such as newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disturbances, and neuromuscular diseases. Natus develops sophisticated computerized neurodiagnostic systems for specialties including audiology, neurology, polysomnography, and neonatology. Furthermore, it supplies software systems designed for the management and tracking of disorders within public health laboratories. Specific solutions encompass electroencephalography (EEG), long-term monitoring, intensive care unit monitoring, electromyography (EMG), comprehensive sleep analysis (polysomnography), and intra-operative monitoring. The company also furnishes products for hearing assessment, screening initiatives, and precision instrument fitting. Additional specialized offerings include jaundice management tools, devices for brain injury, and cutting-edge eye imaging systems specifically engineered for neonatal and pediatric retinal examination. Moreover, Natus provides essential equipment for the daily operations of neonatal intensive care units (NICUs), systems for evaluating balance disorders, and NICVIEW, an innovative live video streaming service that connects families with their infants in the NICU. It also offers computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. The company's diverse clientele includes university medical centers, both public and private hospitals, private physician practices, clinics, and research laboratories worldwide. Established in 1987, the organization was initially known as ALGOTEK Instruments, Inc., before officially changing its name to Natus Medical Incorporated in September 1988. Its corporate headquarters are situated in Middleton, Wisconsin.
| EPS | 1.080 |
| Book Value | 16.340 |
| PEG Ratio | 0.00 |
| Gross Profit | 20.575 |
| Profit Margin (%) | 3.78 |
| Operating Margin (%) | 1.83 |
| Return on Assets (ttm) | 3.7 |
| Return on Equity (ttm) | 7.0 |
Thu, 21 Jul 2022
ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value - GlobeNewswire
Thu, 21 Jul 2022
Natus Medical Incorporated (NTUS) Share Price Today | Natus Medical (NTUS) Live NSE/BSE - Value Research
Tue, 19 Apr 2022
Latham & Watkins Advises ArchiMed Group in US$1.2 Billion Acquisition of Natus Medical Incorporated - Latham & Watkins LLP
Tue, 19 Apr 2022
ArchiMed to Acquire Natus Medical Inc - The Hearing Review
Mon, 18 Apr 2022
Natus Medical to Be Acquired by ArchiMed for $1.2 Billion - Barron's
Mon, 18 Apr 2022
Medical device maker Natus to go private in $1.2 bln deal - Reuters
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |